Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
clinical trials
fda
indiana
3
×
indiana blog main
indiana top stories
life sciences
national blog main
amgen
boston blog main
chronic migraine
drugs
eli lilly
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
alprazolam
antibiotics
arvinas
astrazeneca
boston
boston top stories
boulder/denver
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
carbapenem-resistant enterobacteriaceae
celgene
cgrp inhibitors
colucid pharmaceuticals
detroit
detroit blog main
detroit top stories
drug enforcement administration
entasis therapeutics
episodic migraine
gritstone oncology
guardant health
ipo
kodiak sciences
What
approval
drug
eli
fda
lilly
migraine
new
won
acute
addresses
announced
approved
biotechs
causes
chose
class
close
company
condition
decades
decision
developed
device
firms
friday
giant
giving
headache
ipo
ipos
lasmiditan
late
life
lilly’s
make
marks
medical
medication
medicines
oks
Language
unset
Current search:
indiana
×
photo
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way